Search Results Search Sort by RelevanceMost Recent Letter to the Editor Nov 2016 Response to “Ethical and Clinical Dilemmas in Using Psychotropic Medications During Pregnancy” Jennifer Piel, JD, MD, Suzanne B. Murray, MD, and Carmen Antonela Croicu, MD Treatment of pregnant women with psychosis may involve reconciling conflicting ethical obligations. AMA J Ethics. 2016;18(11):1156-1159. doi: 10.1001/journalofethics.2016.18.11.corr1-1611. Policy Forum Dec 2011 Medicalizing Obesity: Individual, Economic, and Medical Consequences George L. Blackburn, MD, PhD Given the ever-rising costs associated the condition and its associated comorbidities, perhaps it's time to recognize obesity as a medical problem. Virtual Mentor. 2011;13(12):890-895. doi: 10.1001/virtualmentor.2011.13.12.pfor1-1112. Policy Forum Apr 2010 What's Wrong with the U.S. Approach to Obesity? Barry M. Popkin, MS, PhD The U.S.’s and U.K.’s efforts to combat obesity reflect underlying differences in the two countries’ understandings of obesity’s causes. Virtual Mentor. 2010;12(4):316-320. doi: 10.1001/virtualmentor.2010.12.4.pfor2-1004. Policy Forum Sep 2009 Direct-to-Consumer Personal Genome Services: Need for More Oversight Emily E. Anderson, PhD, MPH There is a market for direct-to-consumer genetic testing and a need for better consumer information and more regulation of tests and testing laboratories. Virtual Mentor. 2009;11(9):701-708. doi: 10.1001/virtualmentor.2009.11.9.pfor1-0909. Policy Forum Sep 2009 Emerging Dilemmas in Newborn Screening Don B. Bailey, Jr, PhD, Debra Skinner, PhD, Myra I. Roche, MS, CGC, and Cynthia Powell, MD, MS Research questions must be answered to inform policy decisions about the hereditary diseases and conditions for which newborns should be tested. Virtual Mentor. 2009;11(9):709-713. doi: 10.1001/virtualmentor.2009.11.9.pfor2-0909. Pagination First page « First Previous page ‹ Previous Page 1 Current page 2
Letter to the Editor Nov 2016 Response to “Ethical and Clinical Dilemmas in Using Psychotropic Medications During Pregnancy” Jennifer Piel, JD, MD, Suzanne B. Murray, MD, and Carmen Antonela Croicu, MD Treatment of pregnant women with psychosis may involve reconciling conflicting ethical obligations. AMA J Ethics. 2016;18(11):1156-1159. doi: 10.1001/journalofethics.2016.18.11.corr1-1611.
Policy Forum Dec 2011 Medicalizing Obesity: Individual, Economic, and Medical Consequences George L. Blackburn, MD, PhD Given the ever-rising costs associated the condition and its associated comorbidities, perhaps it's time to recognize obesity as a medical problem. Virtual Mentor. 2011;13(12):890-895. doi: 10.1001/virtualmentor.2011.13.12.pfor1-1112.
Policy Forum Apr 2010 What's Wrong with the U.S. Approach to Obesity? Barry M. Popkin, MS, PhD The U.S.’s and U.K.’s efforts to combat obesity reflect underlying differences in the two countries’ understandings of obesity’s causes. Virtual Mentor. 2010;12(4):316-320. doi: 10.1001/virtualmentor.2010.12.4.pfor2-1004.
Policy Forum Sep 2009 Direct-to-Consumer Personal Genome Services: Need for More Oversight Emily E. Anderson, PhD, MPH There is a market for direct-to-consumer genetic testing and a need for better consumer information and more regulation of tests and testing laboratories. Virtual Mentor. 2009;11(9):701-708. doi: 10.1001/virtualmentor.2009.11.9.pfor1-0909.
Policy Forum Sep 2009 Emerging Dilemmas in Newborn Screening Don B. Bailey, Jr, PhD, Debra Skinner, PhD, Myra I. Roche, MS, CGC, and Cynthia Powell, MD, MS Research questions must be answered to inform policy decisions about the hereditary diseases and conditions for which newborns should be tested. Virtual Mentor. 2009;11(9):709-713. doi: 10.1001/virtualmentor.2009.11.9.pfor2-0909.